InnoCare Pharma Ltd
HKEX:9969

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
HKEX:9969
Watchlist
Price: 5.1 HKD 2.2% Market Closed
Updated: May 19, 2024

InnoCare Pharma Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InnoCare Pharma Ltd
Interest Income Expense Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
HKEX:9969
Interest Income Expense
-¥162.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-¥59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Interest Income Expense
¥445.8m
CAGR 3-Years
N/A
CAGR 5-Years
84%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
¥217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-¥33.6m
CAGR 3-Years
38%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
¥100.8m
CAGR 3-Years
126%
CAGR 5-Years
96%
CAGR 10-Years
N/A

See Also

What is InnoCare Pharma Ltd's Interest Income Expense?
Interest Income Expense
-162.3m CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Interest Income Expense amounts to -162.3m CNY.